These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26824958)

  • 21. Virulence comparison in mice of distinct isolates of type A Francisella tularensis.
    Twine SM; Shen H; Kelly JF; Chen W; Sjöstedt A; Conlan JW
    Microb Pathog; 2006 Mar; 40(3):133-8. PubMed ID: 16448801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen.
    Shen H; Chen W; Conlan JW
    Vaccine; 2004 Jun; 22(17-18):2116-21. PubMed ID: 15149767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PATHOGENESIS AND IMMUNE RESPONSES OF FRANCISELLA TULARENSIS STRAINS IN WILD-CAUGHT COTTONTAIL RABBITS (SYLVILAGUS SPP.).
    Brown VR; Adney DR; Bielefeldt-Ohmann H; Gordy PW; Felix TA; Olea-Popelka FJ; Bowen RA
    J Wildl Dis; 2015 Jul; 51(3):564-75. PubMed ID: 25984770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Francisella tularensis pathogenicity island protein essential for bacterial proliferation within the host cell cytosol.
    Santic M; Molmeret M; Barker JR; Klose KE; Dekanic A; Doric M; Abu Kwaik Y
    Cell Microbiol; 2007 Oct; 9(10):2391-403. PubMed ID: 17517064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis.
    Chen W; KuoLee R; Shen H; Bùsa M; Conlan JW
    Microb Pathog; 2004 Oct; 37(4):185-91. PubMed ID: 15458779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge.
    Tempel R; Lai XH; Crosa L; Kozlowicz B; Heffron F
    Infect Immun; 2006 Sep; 74(9):5095-105. PubMed ID: 16926401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.
    Green M; Choules G; Rogers D; Titball RW
    Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stochastic dynamics of Francisella tularensis infection and replication.
    Carruthers J; Lythe G; López-García M; Gillard J; Laws TR; Lukaszewski R; Molina-París C
    PLoS Comput Biol; 2020 Jun; 16(6):e1007752. PubMed ID: 32479491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short report: time course of hematogenous dissemination of Francisella tularensis A1, A2, and Type B in laboratory mice.
    Eisen RJ; Yockey B; Young J; Reese SM; Piesman J; Schriefer ME; Beard CB; Petersen JM
    Am J Trop Med Hyg; 2009 Feb; 80(2):259-62. PubMed ID: 19190224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.
    Twine S; Byström M; Chen W; Forsman M; Golovliov I; Johansson A; Kelly J; Lindgren H; Svensson K; Zingmark C; Conlan W; Sjöstedt A
    Infect Immun; 2005 Dec; 73(12):8345-52. PubMed ID: 16299332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice.
    Conley J; Yang H; Wilson T; Blasetti K; Di Ninno V; Schnell G; Wong JP
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1288-92. PubMed ID: 9174185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of the relationship between bacterial kinetics and host response for monkeys exposed to aerosolized Francisella tularensis.
    Huang Y; Haas CN
    Appl Environ Microbiol; 2011 Jan; 77(2):485-90. PubMed ID: 21115714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low dose aerosol infection of mice with virulent type A Francisella tularensis induces severe thymus atrophy and CD4+CD8+ thymocyte depletion.
    Chen W; Kuolee R; Austin JW; Shen H; Che Y; Conlan JW
    Microb Pathog; 2005; 39(5-6):189-96. PubMed ID: 16257504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.
    Griffin AJ; Crane DD; Wehrly TD; Bosio CM
    Clin Vaccine Immunol; 2015 Jan; 22(1):119-28. PubMed ID: 25410207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of Francisella tularensis by the polymerase chain reaction.
    Junhui Z; Ruifu Y; Jianchun L; Songle Z; Meiling C; Fengxiang C; Hong C
    J Med Microbiol; 1996 Dec; 45(6):477-82. PubMed ID: 8958253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A.
    Wu TH; Hutt JA; Garrison KA; Berliba LS; Zhou Y; Lyons CR
    Infect Immun; 2005 May; 73(5):2644-54. PubMed ID: 15845466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional profiling of host responses in mouse lungs following aerosol infection with type A Francisella tularensis.
    Andersson H; Hartmanová B; KuoLee R; Rydén P; Conlan W; Chen W; Sjöstedt A
    J Med Microbiol; 2006 Mar; 55(Pt 3):263-271. PubMed ID: 16476789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection afforded against aerosol challenge by systemic immunisation with inactivated Francisella tularensis live vaccine strain (LVS).
    Eyles JE; Hartley MG; Laws TR; Oyston PC; Griffin KF; Titball RW
    Microb Pathog; 2008 Feb; 44(2):164-8. PubMed ID: 17904793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitogen-activated protein kinases (MAPKs) are modulated during Francisella tularensis infection, but inhibition of extracellular-signal-regulated kinases (ERKs) is of limited therapeutic benefit.
    Saint RJ; D'Elia RV; Bryant C; Clark GC; Atkins HS
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):2015-2024. PubMed ID: 27714591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human Dose-Response Data for Francisella tularensis and a Dose- and Time-Dependent Mathematical Model of Early-Phase Fever Associated with Tularemia After Inhalation Exposure.
    McClellan G; Coleman M; Crary D; Thurman A; Thran B
    Risk Anal; 2018 Aug; 38(8):1685-1700. PubMed ID: 29694682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.